rivastigmine 9.5 MG/Day 24 HR Transdermal Patch

RxCUI: 725023
RxNorm name: rivastigmine 9.5 MG/Day 24 HR Transdermal Patch
Display name: rivastigmine 9.5 MG/Day 24 HR Transdermal Patch
Full name: rivastigmine 9.5 MG/Day 24 HR Transdermal Patch
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rivastigmine	RIVASTIGMINE	Zydus Lifesciences Limited	966d59ea-5cea-4fef-8b96-e0efe885caf4	2025-11-17		Exact identifier rxcui: 725023
Rivastigmine	RIVASTIGMINE	Northstar Rx LLC.	8b809739-8381-4cc1-ab4a-5b17ab902a3d	2025-11-14	Warnings, Adverse reactions	Exact identifier rxcui: 725023
Rivastigmine Transdermal System	RIVASTIGMINE	Bryant Ranch Prepack	a68d70c9-19f2-47db-bf78-4da04a87a702	2025-03-20	Warnings, Adverse reactions	Exact identifier rxcui: 725023
Rivastigmine Transdermal System	RIVASTIGMINE	Breckenridge Pharmaceutical, Inc.	b201fe68-b5e5-4a6f-8cf1-069543f03e76	2025-01-15	Warnings, Adverse reactions	Exact identifier rxcui: 725023
Rivastigmine Transdermal System	RIVASTIGMINE	Bryant Ranch Prepack	1ebeb8ec-5348-4bb1-ab3d-834690351094	2024-12-24	Warnings, Adverse reactions	Exact identifier rxcui: 725023
Rivastigmine	RIVASTIGMINE	Mylan Pharmaceuticals Inc.	4ab335d1-19ee-4cd9-9776-8086645d19e4	2024-09-21	Warnings, Adverse reactions	Exact identifier rxcui: 725023
Rivastigmine	RIVASTIGMINE	Amneal Pharmaceuticals LLC	8b671fc9-8cb0-4406-a9ee-7c95086d6200	2024-07-02	Warnings, Adverse reactions	Exact identifier rxcui: 725023
Rivastigmine Transdermal System	RIVASTIGMINE	Bryant Ranch Prepack	c569f760-f311-42ba-909c-a36319622b35	2024-05-30	Warnings, Adverse reactions	Exact identifier rxcui: 725023
Rivastigmine	RIVASTIGMINE	Zydus Pharmaceuticals USA Inc.	64dad603-2389-456b-8c18-d1d40b7e7419	2024-05-27	Warnings, Adverse reactions	Exact identifier rxcui: 725023
Rivastigmine	RIVASTIGMINE	Sandoz Inc	92a58ebb-748d-49f4-bf11-ecbcf5424152	2024-05-08	Warnings, Adverse reactions	Exact identifier rxcui: 725023
Exelon	RIVASTIGMINE	Novartis Pharmaceuticals Corporation	07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0	2024-05-08	Warnings, Adverse reactions	Exact identifier rxcui: 725023
Exelon	RIVASTIGMINE	Sandoz Inc	b6ed6d15-116d-4596-92ce-3414574d7ba0	2024-05-08	Warnings, Adverse reactions	Exact identifier rxcui: 725023

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 14 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
c569f760-f311-42ba-909c-a36319622b35	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	110	These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000	20240530
a68d70c9-19f2-47db-bf78-4da04a87a702	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	107	These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000	20250320
1ebeb8ec-5348-4bb1-ab3d-834690351094	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	100	These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000	20241224
07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	30	These highlights do not include all the information needed to use EXELON PATCH safely and effectively. See full prescribing information for EXELON PATCH. EXELON ® PATCH (rivastigmine transdermal system) Initial U.S. Approval: 2000	20240508
8b671fc9-8cb0-4406-a9ee-7c95086d6200	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	17	These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000	20240702
4ab335d1-19ee-4cd9-9776-8086645d19e4	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	10	These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000	20240921
8b809739-8381-4cc1-ab4a-5b17ab902a3d	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	7	These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 2000	20251114
b201fe68-b5e5-4a6f-8cf1-069543f03e76	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	7	These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000	20250115
92a58ebb-748d-49f4-bf11-ecbcf5424152	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	5	These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE TRANSDERMAL SYSTEM Initial U.S. Approval: 2000	20240508
64dad603-2389-456b-8c18-d1d40b7e7419	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	4	These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 2000	20240527
7d8414f5-b51f-4ccb-b7a1-83b9ede5b266	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	3	These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 2000	20221004
29481887-34eb-460a-bd7f-b8755473065a	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	2		20100222
966d59ea-5cea-4fef-8b96-e0efe885caf4	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	1	Rivastigmine Transdermal System	20251117
b6ed6d15-116d-4596-92ce-3414574d7ba0	rivastigmine 9.5 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.396 MG/HR Transdermal System [SCD] · rivastigmine 0.396 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 9.5 MG/Day 24HR Transdermal System [SY]	5	1	These highlights do not include all the information needed to use EXELON PATCH safely and effectively. See full prescribing information for EXELON PATCH. EXELON ® PATCH (rivastigmine transdermal system) Initial U.S. Approval: 2000	20240508